In episode 26 the pharmaphorum podcast hears from David Solomon, a 30-year life sciences industry veteran who recently took up the position of CEO at the Paris-based biopharmaceutical company Pharnext.
Regenerative medicine and COVID: the pharmaphorum podcast
Pharmacy and clinical research: the pharmaphorum podcast
Pharma’s post-COVID prospects: the pharmaphorum podcast
Galapagos UK’s Michael Smyth on COVID and RNA-based tech: the pharmaphorum podcast
Big data and cell therapy development: the pharmaphorum podcast
GSK on COVID and vaccine development: the pharmaphorum podcast
The meaning of digital innovation: the pharmaphorum podcast
New ways to treat COVID: the pharmaphorum podcast
The Alderley Park Discovery Podcast: The journey to accessing science funding and investment
Roche on COVID healthcare and testing: the pharmaphorum podcast
Richard Francis discusses his new role as Purespring’s CEO: pharmaphorum podcast
AstraZeneca’s Rebekah Martin on diversity and inclusion: the pharmaphorum podcast
The Alderley Park Discovery Podcast: Life science skills, staffing and support
J&J and medical device innovation: the pharmaphorum podcast
GSK and eosinophil research: the pharmaphorum podcast
Gitte Aabo on telemedicine and her time at LEO Pharma: the pharmaphorum podcast
The Alderley Park Discovery Podcast: COVID testing and the Lighthouse Lab
Alnylam, gene-silencing and biotech in 2020: the pharmaphorum podcast
Novartis, company culture and COVID-19: the pharmaphorum podcast
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Stuff To Blow Your Mind
Unexplainable
Speaking of Psychology